s Certifying Accountant
On May 2, 2016, DS Healthcare Group, Inc. (the Company) terminated its independent registered public accounting firm, Marcum LLP (Marcum), and appointed MaloneBailey, LLP (MaloneBailey) as the Companys new independent registered public accounting firm.
The audit report of Marcum on the Companys financial statements for the years ended December 31, 2014 and 2013 did not contain an adverse opinion or disclaimer of opinion, and was not qualified or modified as to uncertainty, audit scope or accounting principles, except that the audit report stated that there was substantial doubt about the Companys ability to continue as a going concern.
During the two years ended December 31, 2014 and through the subsequent period preceding Marcum s termination, there were no disagreements between the Company and Marcum on any matter of accounting principles or practices, financial statement disclosure, auditing scope or procedures, which disagreements if not resolved to the satisfaction of Marcum, would have caused them to make reference thereto in their reports on the Companys financial statements for such years. During the two years ended December 31, 2014 and through the subsequent period preceding Marcums termination, there were the following reportable events within the meaning set forth in Item 304(a)(1)(v) of Regulation S-K:
Marcum advised the Company that the internal controls necessary for the Company to develop reliable financial statements do not exist, as reported in the Companys Form 10-K for its fiscal year ended December 31, 2013 and Form 10-K for its fiscal year ended December 31, 2014.
Marcum advised the Company that it needed to expand significantly the scope of its audit to address the concerns related to revenue recognition and stock issuances as disclosed in the Companys 8-K filing dated March 23, 2016, as well as management integrity. Marcum discussed the proposed expansion in audit scope with Daniel Khesin, the Companys President but did not discuss the proposed expansion in audit scope with any audit or similar committee of the board of directors, or the board of directors. The Company has authorized Marcum to respond fully to the inquiries of the successor accountant concerning the foregoing. Marcums concerns regarding revenue recognition, stock issuances and management integrity, if further investigated, could (i) materially impact the fairness or reliability of either: a previously issued audit report or the underlying financial statements; or the financial statements issued or to be issued covering the fiscal period(s) subsequent to the date of the most recent financial statements covered by an audit report (including information that may prevent Marcum from rendering an unqualified audit report on those financial statements), or (ii) cause Marcum to be unwilling to rely on management's representations or be associated with the registrant's financial statements. Due to Marcums dismissal, it did not so expand the scope of its audit or conduct such further investigation.
During the two most recent fiscal years ended December 31, 2015 and through the subsequent interim period prior to the Companys appointment of MaloneBailey, the Company did not consult with MaloneBailey on either (1) the application of accounting principles to a specified transaction, either completed or proposed, (2) the type of audit opinion that may be rendered on the Companys financial statements; or (3) any matter that was either the subject of a disagreement, as defined in Item 304(a)(1)(iv) of Regulation S-K, or a reportable event, as defined in item 304(a)(1)(v) of Regulation S-K. In addition, MaloneBailey did not provide any written or oral advice to the Company that MaloneBailey concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue.
The Company has provided Marcum with a copy of the disclosures in this Form 8-K and has requested that Marcum furnish it with a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the Companys statements herein. A copy of the letter dated May 6, 2016 is filed as Exhibit 16.1 to this Form 8-K.
Item 9.01 Financial Statements and Exhibits
Description of Exhibit
Letter from Marcum to the Securities and Exchange Commission dated May 6, 2016
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DS HEALTHCARE GROUP, INC.
Date: May 6, 2016
makes a similar move, sign up!